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Summary
Objective: Determine the kinetics of collagen crosslinking in adult bovine articular cartilage explants using radiolabel pulse-chase studies.
Methods: Explant cultures of adult bovine articular cartilage were radiolabeled with [14C]lysine in medium including fetal bovine serum and
ascorbate, and then maintained for chase periods up to 28 days. In some samples, b-aminopropionitrile (BAPN) was included during chase to
inhibit lysyl oxidase-mediated collagen crosslinking. Tissue was hydrolyzed and analyzed for [14C]metabolites in the forms of lysine,
hydroxylysine, dehydrodihydroxylysinonorleucine (DDHLNL), and hydroxylysyl pyridinoline (HP).
Results: Explant cultures of adult bovine articular cartilage metabolized lysine into hydroxylysine and the collagen crosslinks, DDHLNL and
HP. During chase, [14C]hydroxylysine maintained steady-state levels, [14C]DHLNL rose to a plateau, and [14C]HP increased gradually.
Addition of BAPN inhibited formation of [14C]DHLNL. Analysis of raw data and that normalized to [14C]hydroxylysine gave characteristic time
constants for formation of DDHLNL and HP crosslinks of 1e2 and 7e30 days, respectively. The distribution of [14C]lysine metabolites in
collagen crosslinks was described by peak values in [14C]DHLNL/[14C]hydroxylysine of 0.047e0.064 and in [14C]HP/[14C]hydroxylysine
of 0.03.
Conclusion: Collagen crosslinks form in cartilage explants in vitro according to the classical lysyl oxidase-mediated pathway.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The integrity and tensile properties of articular cartilage are
attributed primarily to the ﬁbrillar collagen meshwork1,2.
Formation of the collagen meshwork in connective tissues
involves biosynthesis, secretion and extracellular process-
ing3. Collagen polypeptides are synthesized, hydroxylated
and glycosylated within the chondrocyte. After triple-helix
formation and secretion, collagen molecules are modiﬁed
extracellularly by endopeptidase cleavage of portions of
non-helical regions of collagen and deposited in ﬁbrils.
Subsequent ﬁbril stabilization is dependent on collagen
crosslinks, the covalent bonds between individual collagen
molecules.
During post-natal growth, the major collagen crosslinks
that are present in articular cartilage are the difunctional
crosslink, dehydrodihydroxylysinonorleucine (DDHLNL)
and the trifunctional crosslink, hydroxylysyl pyridinoline
(HP)4. In young (2-month old) calf articular cartilage, the
content of DDHLNL and HP is 0.81 and 0.85 mol/mol
collagen triple helix, respectively. In articular cartilage from
the skeletally mature adult bovine, the content of DDHLNL
has fallen to 0.04 mol/mol collagen, while the HP content of
mature rabbit, bovine, and human articular cartilage has
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oxidase-derived trifunctional crosslink, lysyl pyridinoline, is
only 1e3% as abundant as HP in articular cartilage5,7.
Collagen crosslinks formed through non-enzymatic glyca-
tion processes accumulate slowly in adult cartilage during
aging5,8, but not during growth5.
The metabolic pathway for the formation of DDHLNL and
HP crosslinks, and the critical involvement of the enzyme
lysyl oxidase, has been reviewed6,9e11 and summarized in
Fig. 1. Lysyl oxidase catalyzes the conversion of lysine and
hydroxylysine amines into their aldehyde forms, allysine
and hydroxyallysine, respectively. In articular cartilage,
hydroxyallysine in the non-helical ends of collagen mole-
cules11 reacts with a hydroxylysine amine on an adjacent
molecule to form DDHLNL. As HP consists of three
hydroxylysine residues, it appears that two DDHLNL
crosslinks can react to form an HP crosslink and release
a single hydroxylysine amine (in the helical region of
a collagen molecule)6.
Lysyl oxidase-mediated collagen crosslink formation is
important for the remodeling of articular cartilage, as well as
other connective tissues. In lathyritic animals, where
enzyme-mediated collagen crosslinking has been inhibited,
the mechanical properties of connective tissue are greatly
diminished and collagen ﬁbril distribution is altered12. In
vitro, lysyl oxidase is inhibited by b-aminopropionitrile
(BAPN) with a 50% inhibition at 3e5 mM13. Animals treated
with BAPN have exhibited decreased wound healing in
various tissues in vivo14,15. In vitro, incubation of cartilage
explants with BAPN inhibits functional integration between9
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of newly-synthesized collagen16,17.However, it is not known
if such BAPN treatment of cartilage explants speciﬁcally
inhibits collagen crosslink formation.
Relatively little quantitative information is available on the
kinetics of formation of DDHLNL and HP in articular
cartilage. In vivo studies have used [14C]lysine in pulse-
chase experiments to examine crosslink formation in the
articular cartilage of rabbits18. Similar approaches have
been used to assess crosslink formation in the skin, tendon,
and bone of rats19. In these various collagenous tissues,
[14C]DHLNL peaks between 5 days and 2 weeks. However,
in vivo it is difﬁcult to estimate or control the speciﬁc activity
of radioactivity of the [14C]lysine metabolic precursor within
the articular cartilage20. In vitro systems allow precise
control of the biochemical milieu, including regulatory
factors for articular cartilage. Explant cultures of bovine
articular cartilage have been used extensively to study
matrix metabolism21. However, it is unknown if extracellular
processing of collagen, mediated by lysyl oxidase, occurs in
cartilage explants and, if so, the kinetics of this processing.
The objectives of this study were to determine the kinetics
of formation of hydroxylysine and the DDHLNL and HP
crosslinks in explant cultures of adult bovine articular
cartilage using pulse-chase studies with [14C]lysine and
the susceptibility of DDHLNL formation to BAPN treatment
during chase.
Fig. 1. A simpliﬁed representation of lysine metabolism and
collagen crosslinking in articular cartilage. Indicated is the
conversion of lysine into hydroxylysine and the DDHLNL and HP
crosslinks, as well as the lysyl hydroxylase- and lysyl oxidase-
mediated processes.Experimental procedures
MATERIALS
Materials for tissue explant and culture22, and biochem-
ical analyses23,24 were obtained as described previously. In
addition, specially formulated lysine-free Dulbecco’s Mod-
iﬁed Eagle Medium (DMEM) was from Gibco (Grand Island,
NY) and L-[14C(U)]lysine (317 mCi/mmol) was from DuPont
New England Nuclear (Boston, MA).
CARTILAGE EXPLANT
Cartilage explants were harvested from the patellofe-
moral groove of adult bovine animals essentially as
described previously22,25. After removing w0.3 mm of the
tissue from the articular surface, plane parallel slices
(0.25 mm thick) of cartilage were sectioned. From these
slices, 3-mm diameter disks were formed.
PULSE-CHASE STUDIES
Two studies were performed. The ﬁrst, short-term, study
focused on the kinetics of conversion of [14C]lysine into
[14C]hydroxylysine and [14C]DHLNL over a period of days,
up to 2 weeks. The second, long-term, study examined the
kinetics of conversion of [14C]lysine into [14C]hydroxylysine,
[14C]DHLNL, and [14C]HP over a period of weeks, up to 4
weeks.
Short-term study
Cartilage was harvested from four animals. For each
animal, disks from individual slices were distributed equally
among ﬁve different experimental sample groups to form
a data set. Samples, each consisting of 25 disks, were
maintained in medium (DMEM, 100 mg/ml ascorbate,
0.4 mM proline, 2 mM L-glutamine, 10 mM HEPES,
0.1 mM non-essential amino acids and antibiotic/antimy-
cotic) in a humidiﬁed 5% CO2e95% air incubator at 37(C at
a ratio of 20:1 (medium volume:tissue volume) with medium
changes every 48 h. Initially, samples were incubated for 5
days in medium supplemented with 20% fetal bovine serum
(FBS) to stimulate and stabilize biosynthetic rates26. To
deplete extracellular lysine, samples were washed three
times over 2 h in medium with lysine-free DMEM. Samples
were then pulsed for 1 day in medium with lysine-free
DMEM supplemented with 20% FBS and 5 mCi/ml [14C]ly-
sine. To remove unincorporated radiolabel, samples were
washed in medium supplemented with 20% FBS. One
sample of each data set was terminated, while the others
were chased for an additional 2, 5, 7 or 14 days in medium
supplemented with 20% FBS, in the presence or absence of
0.25 mM BAPN. At termination, samples were transferred to
Pyrex tubes and stored at 20(C.
Samples were analyzed for radiolabeled lysine, hydrox-
ylysine and DDHLNL residues after reduction and hydroly-
sis essentially as described previously7,24, except the
radiolabeling of the amino acid metabolites was derived
from the [14C]lysine instead of by reduction with [3H]NaBH4.
All samples were washed with water to remove traces of
medium before being reduced with 5 ml of 0.8 mM NaBH4 in
phosphate buffered saline (pH 7.4) for 15 min. Samples
were then washed again and hydrolyzed for 20 h in 6 N HCl.
Hydrolysates were dehydrated overnight with a vacuum
pump, rehydrated in 0.5 ml of 0.1 N HCl, and ﬁltered
(0.4 mm). Portions of the hydrolysates were analyzed for
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performance liquid chromatography (HPLC) on a cation-
exchange column (4 mm diameter! 250 mm length, Pick-
ering Laboratories, Mountain View, CA) and an in-line
radioactivity detector (Packard Instruments A100). Any
naturally-occurring reduction of DDHLNL was included in
the DDHLNL levels measured, although the proportion of
DDHLNL that was naturally-reduced was not measured. For
normalization purposes, portions of the hydrolysates were
also analyzed for hydroxyproline by a colormetric re-
action24,27 since it is known that the content of hydroxypro-
line in such cultures is approximately constant26. The mass
of collagen was calculated as 7.46 times the mass of
hydroxyproline28.
Long-term study
Cartilage was harvested from three animals. For each
animal, disks from individual slices were distributed equally
among ﬁve different experimental groups to form a data set.
As above, samples (here consisting of 40e44 disks) were
incubated for 5 days and washed for 2 h. In this study,
samples were pulsed for 6 days in medium with lysine-free
DMEM supplemented with 20% FBS and 5 mCi/ml [14C]ly-
sine, and then washed with medium with 20% FBS. One
sample of each data set was terminated, while the others
were incubated for an additional 7, 14, 21 or 28 days in
medium supplemented with 20% FBS. Samples were
stored as described above.
Samples were analyzed for radiolabeled lysine, hydro-
xylysine, DDHLNL and HP residues after reduction and
hydrolysis essentially as described previously7,29, except
quantitating [14C]HP by radioactivity detection instead of
total HP by spectroﬂuorometry. In preparation for HPLC,
samples were washed, reduced with sodium borohydride
(5 ml of 1.6 mM), hydrolyzed, and dehydrated as described
above and then rehydrated in 1% heptaﬂuorobutyric acid
(HFBA) and ﬁltered. As above, the HPLC and radioactivity
detection system was used to analyze portions of hydro-
lysates for [14C]lysine, [14C]hydroxylysine, and [14C]DHLNL.
A similar system, except using a reverse-phase column
(4 mm diameter! 250 mm length, S5ODS2, Spherisorb,
Queensferry, England), was used to analyze portions of
hydrolysates for [14C]HP. In a pilot study, total HP levels
were maintained within 1% of native values after NaBH4
reduction. As above, all samples were also analyzed for
collagen (hydroxyproline).
ANALYSIS
All data are expressed as meanG S.E.M. The effects of
chase time (and BAPN where relevant) on the measured
quantities of [14C]labeled metabolites were analyzed by
one-way (or two-way) ANOVA with post-hoc analysis using
the Tukey test. In addition, to provide information about the
distribution of [14C]lysine metabolites in the cartilage
explants, the following ratios were calculated: [14C]hydrox-
ylysine to [14C]lysine, [14C]DHLNL to [14C]lysine, and
[14C]HP to [14C]lysine. To provide information about the
distribution of [14C]lysine metabolites in collagen crosslinks,
the following ratios were calculated: [14C]DHLNL to
[14C]hydroxylysine and [14C]HP to [14C]hydroxylysine. Time
constants (t1/2) for DDHLNL and HP crosslink formation
were determined as the chase times to reach half-
maximum values, by linear interpolation or extrapolation of
the data.Results
SHORT-TERM STUDY
The conversion of lysine into hydroxlysine and DDHLNL
crosslink was examined with samples that were pulsed for 1
day and chased for up to 14 days (Fig. 2). Comparison of
pulse samples (0 day chase) to chase samples, incubated
in normal medium (without BAPN), indicated that with chase
time, there was a signiﬁcant decrease in [14C]lysine
(P! 0.001), but no change in [14C]hydroxylysine
[PZ 0.95, Fig. 2(A)]. The ratio of [14C]hydroxylysine to
[14C]lysine increased from 0.25 after the pulse period to
0.48 after 14 days of chase. [14C]DHLNL levels showed
a tendency to increase to a plateau with time (PZ 0.08)
during 2e14 days of chase [Fig. 2(B)]. After 14 days of
chase, the ratio of [14C]DHLNL to [14C]lysine was 0.03.
Treatment of radiolabeled samples with BAPN during the
chase period had selective effects on the kinetics of
[14C]lysine metabolism. During 2e14 days of chase,
[14C]lysine and [14C]hydroxylysine contents were unaf-
fected by BAPN treatment (PO 0.8 each) or chase time
(PO 0.2 each). In contrast to an absence of effect on
[14C]lysine and [14C]hydroxylysine, BAPN had a marked
effect on the metabolism of [14C]DHLNL crosslinks, causing
a marked reduction in [14C]DHLNL (P! 0.001). Throughout
Fig. 2. Kinetics of [14C]lysine metabolism and [14C]DHLNL formation
in control (j,C,¤) and BAPN-treated (+,:, ) cartilage samples
following 1 day of pulse labeling with [14C]lysine. Radioactivity,
normalized to collagen, in the form of (A) [14C]lysine (j,+) and
[14C]hydroxylysine (C,:), as well as (B) [14C]DHLNL(¤, ), as
a function of chase time. MeanG S.E.M., nZ 3e4.
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did not vary signiﬁcantly (PZ 0.13). After 14 days of chase,
the ratio of [14C]DHLNL to [14C]lysine was 0.01 for BAPN-
treated samples.
Normalization of [14C]DHLNL to [14C]hydroxylysine in
each sample resulted in a marked reduction in variability
[compare Figs. 2(B) and 3]. During chase in normal
medium, the ratio of [14C]DHLNL to [14C]hydroxylysine
reached a peak (PZ 0.06), ranging from 0.058 to 0.064 at
2e7 days of chase. Since this ratio (Fig. 3), as well as the
[14C]DHLNL levels [Fig. 2(B)], was essentially at its peak by
the 2-day chase point, and this ratio was close to half-
maximum immediately after the 1-day pulse period, the t1/2
for [14C]DHLNL formation wasw1e2 days. During chase in
medium with BAPN, the ratio of [14C]DHLNL to [14C]hydrox-
ylysine did not vary signiﬁcantly (PO 0.9).
LONG-TERM STUDY
To examine the kinetics of both DDHLNL and HP
formation, samples were pulsed for 6 days and chased for
up to 28 days (Fig. 4). During the chase time, the content of
both [14C]lysine and [14C]hydroxylysine remained approxi-
mately constant [PZ 0.48 and PZ 0.84, respectively;
Fig. 4(A)]. [14C]DHLNL levels peaked at day 7 of chase,
but the variation with chase time was not statistically
signiﬁcant (PZ 0.50). Between 7 and 28 days of chase, the
ratio of [14C]DHLNL to [14C]lysine was w0.02. [14C]HP
levels did vary signiﬁcantly (PZ 0.01) with chase time, and
increased to a peak at 21e28 days of chase. The ratio of
[14C]HP to [14C]lysine increased nearly 6-fold, from 0.004 in
the pulse sample to 0.022 in the sample chased for 28 days.
Just as for the analysis of the previous short-term study,
normalization of the long-term [14C]DHLNL and [14C]HP
data to [14C]hydroxylysine in each sample resulted in
a marked reduction in variability [compare Figs. 4(B) and
5]. The ratio of [14C]DHLNL to [14C]hydroxylysine varied
signiﬁcantly with chase time [Fig. 5(A), P! 0.001]. It
reached a peak of 0.047 at 7 days of chase and
subsequently decreased to 0.032 (34%) by 21e28 days
of chase. Opposite to this, the ratio of [14C]HP to
[14C]hydroxylysine [Fig. 5(B)], which also varied signiﬁcantly
with chase time (P! 0.05), was low (0.009) at 0e7 days
Fig. 3. Normalized data from Fig. 2 for control (¤) and BAPN-
treated ( ) cartilage samples following 1 day of pulse labeling with
[14C]lysine. Radioactivity in [14C]DHLNL normalized to [14C]hydrox-
ylysine. MeanG S.E.M., nZ 3e4.of chase, and then increased to a peak (0.025) by 21e28
days of chase. The chase time at which [14C]HP reached
half of this peak was t1/2Z 7 days. The total [
14C]crosslinks
(taken as the sum of [14C]DHLNL and [14C]HP), normalized
to [14C]hydroxylysine, was steady throughout the chase
period, being 0.050 at the 0-day chase point and
0.055e0.057 at 7e28 days of chase. Assuming all
[14C]DHLNL crosslinks would be converted to [14C]HP,
the extrapolated chase time at which [14C]HP would reach
half-maximum (0.028) was t1/2Z 30 days.
Discussion
This study showed that explant cultures of adult bovine
articular cartilage, maintained in medium including FBS and
ascorbate for chase periods up to 28 days, metabolize
lysine into hydroxylysine and the collagen crosslinks,
DDHLNL and HP. Analysis of tissue for radiolabeled
metabolites after pulse-chase protocols using [14C]lysine
revealed (Figs. 2 and 4) an initial decrease and then
stabilization of levels of [14C]lysine, a steady level of
[14C]hydroxylysine, a peak in [14C]DHLNL, and a gradual
increase in [14C]HP. The presence of 0.25 mM BAPN
during the chase period did not affect [14C]lysine or
[14C]hydroxylysine levels, but did inhibit the formation of
Fig. 4. Kinetics of [14C]lysine metabolism and formation of
[14C]DHLNL and [14C]HP crosslinks in cartilage samples following
6 days of pulse labeling with [14C]lysine. Radioactivity, normalized
to collagen, in the form of (A) [14C]lysine (j) and [14C]hydroxylysine
(C), as well as (B) [14C]DHLNL (¤) and [14C]HP (:), as a function
of chase time. MeanG S.E.M., nZ 3.
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data, and that normalized to [14C]hydroxylysine, gave
characteristic time constants and relative distributions of
[14C]lysine metabolites in newly-formed collagen. The t1/2
for the formation of DDHLNL and HP crosslinks was 1e2
and 7e30 days, respectively. The ﬁnal ratios of [14C]hy-
droxylysine, [14C]DHLNL, and [14C]HP each to [14C]lysine
were 0.48e0.66, 0.03, and 0.02, respectively. To provide
information about the distribution of [14C]lysine metabolites
in collagen crosslinks, the peak ratios of [14C]DHLNL and
[14C]HP each to [14C]hydroxylysine (Figs. 4 and 5) were
determined and found to be 0.047e0.064 and 0.03,
respectively.
There are several approaches that could be used to
assess the kinetics of formation of collagen crosslinks. In
these studies, the metabolites of radioactive lysine were
analyzed from entire tissue samples. Additional processing
may have provided supplementary information. For exam-
ple, puriﬁcation of collagen before analyzing metabolites
would have allowed characterization of the crosslinks
(associated with particular collagens). Also, analysis of
the medium for radioactive macromolecular products would
have allowed consideration of all radioactive molecules,
and not solely those deposited within the explant. However,
such approaches would have made more difﬁcult the
detection of radiolabeled crosslinks in the explant, which
was made possible by using a high speciﬁc activity of
[14C]lysine during the pulse period. It is also possible that
Fig. 5. Normalized data from Fig. 4 for cartilage samples following 6
days of pulse labeling with [14C]lysine. Radioactivity in (A)
[14C]DHLNL and (B) [14C]HP normalized to [14C]hydroxylysine.
MeanG S.E.M., nZ 3.difunctional and trifunctional crosslinks could be formed
from multiple radiolabeled lysine residues (rather than one
labeled residue and the other(s) being unlabeled). This
would result in an overestimation of the proportion of
crosslinks that were formed. However, autoradiography
studies of radiolabeled collagen both in vivo18 and in
explants30 showed that with increased chase time, radio-
activity spread throughout the interterritorial matrix. As the
newly-synthesized collagen is not limited to forming cross-
links with other newly-synthesized collagen molecules, the
abundance of existent collagen decreases the likelihood of
multiple [14C]lysine metabolites within a single crosslink.
In these pulse-chase studies, the relative distribution of
lysine metabolites within collagen can be calculated. After
the long chase times in the 6-day pulse studies, the
experimentally determined ratio of [14C]hydroxylysine to
[14C]lysine ranged from 0.63 to 0.73. These results are
consistent with in vivo studies18 and amino acid analysis of
pepsin-digested fragments of collagen type II31, where the
hydroxylysine to lysine ratios in collagen are 0.92 and 0.64,
respectively.
These studies also provide information on the proportion
of [14C]hydroxylysine that crosslink and of [14C]DHLNL that
matures. Assuming that a collagen alpha chain contains 14
hydroxylysine residues31, of which one may become
crosslinked32, the ratio of crosslink to hydroxylysine would
be 0.08, which is fairly close to the 0.056 value found after
2e4 weeks of chase. Using the ratio of hydroxylysines to
collagen molecules, the ratio of DDHLNL to collagen was
1.18. While only a low proportion of hydroxylysines form
crosslinks, 60% of the formed [14C]DHLNL was found to
mature into [14C]HP during the 4-week chase interval.
Considering the relatively low ratio of DDHLNL to HP in
adult bovine articular cartilage (0.03), it may be surprising
that such a signiﬁcant proportion of [14C]DHLNL persisted.
However, the maximum chase time (28 days) was short
compared to the half-life of collagen and the age difference
in bovines (2 months to 2 years) between which DDHLNL
decreases4. The ratio of newly-formed HP to collagen was
determined to be 0.42, smaller than the 1e1.5 ratio
previously determined for adult cartilage4,7,33, but ap-
proaching the 0.5e0.8 ratio in calf tissue4,33. Thus, it is
possible that longer chase times are necessary to allow
complete maturation, from DDHLNL crosslinks to HP
crosslinks. Alternatively, it is possible that events that occur
during collagen maturation in vivo are not precisely
recapitulated in vitro.
The t1/2 of [
14C]DHLNL and [14C]HP, 1e2 and 7e30 days,
respectively, is generally consistent with the ﬁndings of
previous studies. In vivo studies of rat bone19 and rabbit
articular cartilage18 showed that reducible crosslinks
reached a maximum between 5 days and 2 weeks. Studies
that quantiﬁed crosslinks in chondrocytes cultured in
alginate beads showed an 18-fold increase in HP between
7 and 28 days34.
The conversion of hydroxylysine to DDHLNL was
inhibited using BAPN, an irreversible inhibitor of lysyl
oxidase13. The effectiveness of 0.25 mM BAPN in inhibiting
this conversion is consistent with the 3e5 mM concentra-
tion13 needed to block lysyl oxidase in solution. This
concentration has little or no discernible effect on cartilage
matrix biosynthesis in bovine cartilage from adult animals
and coincides with an inhibition of integrative repair in
vitro16,17.
Other forms of crosslinking may be important in the
stabilization of the collagen matrix. Non-enzymatic glycation
products can lead to a stiffening of the collagen matrix35,
714 T. Ahsan et al.: Kinetics of collagen crosslinking in cartilagealthough they are more prevalent in aged tissue8,35. Also,
transglutamination reactions can lead to collagen network
bonding36,37. However, since lysyl oxidase inhibition with
BAPN decreases the measurable adhesive strength be-
tween apposed cartilage explants in culture to near zero16,
these other crosslinks may not be produced with enough
frequency during this short culture period to affect in-
tegrative repair in vitro.
The kinetics of crosslink formation may have implications
for the functional repair or regeneration of articular cartilage.
Although the exact relationship between collagen cross-
linking and the structure and function of articular cartilage
remains to be clariﬁed, the formation of such crosslinks is
associated with the development of mechanical strength
and tissue integration. The deﬁnition of regulatory factors
that modulate the formation of such crosslinks may be
critical to understanding repair processes in articular
cartilage and other connective tissues.
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